Xeljanz
/Xeljanz (tofacitinib) is a Janus kinase (JAK) inhibitor used to treat moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It is administered as an oral tablet and is available by prescription only. Patients are advised that Xeljanz may increase the risk of serious infections and should not be used in patients with active infections or those who have had a recent live vaccine.
FAQs about Xeljanz
How long does it take to work?
The onset of action for Xeljanz (tofacitinib) can vary among patients. Some may begin to notice improvements in their symptoms within a few weeks, while others may take longer. It is important to follow up with your healthcare provider to assess your response to the medication.
What should I do if I miss a dose?
If you miss a dose of Xeljanz, take it as soon as you remember on the same day. However, if it is almost time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time to make up for a missed dose. This information is provided in the Patient Counseling Information section of the label.
Can I take Xeljanz while pregnant or breastfeeding?
The use of Xeljanz during pregnancy should be discussed with your healthcare provider, as the effects on the fetus are not fully known. It is also advised to consider the potential risks and benefits of taking Xeljanz while breastfeeding, as it is not known if tofacitinib is excreted in human milk. Consult your healthcare provider for personalized guidance.
Can I stop taking Xeljanz suddenly?
It is not recommended to stop taking Xeljanz abruptly without consulting your healthcare provider. Discontinuation may lead to a worsening of your condition. Always discuss any changes to your medication regimen with your healthcare provider.
How should I store Xeljanz?
Xeljanz should be stored at room temperature, away from moisture and heat. Keep the medication in its original container and out of reach of children. Proper storage helps maintain the effectiveness of the medication.
25
commonly-prescribed
medication.

